Recepta Biopharma, a Brazilian company, has signed a licensing agreement with Mersana Therapeutics, under which the US-based company's technology will be used to produce a monoclonal antibody (mAb) that can be deployed for ...
Aug 10, 2015
0
11
Sanford-Burnham Medical Research Institute (Sanford-Burnham) today announced that it has signed a licensing agreement to further develop a first-in-class small molecule with Daiichi Sankyo for the treatment of cardiovascular-metabolic ...
Apr 2, 2015
0
3
Swiss-based pharmaceuticals giant Novartis said Wednesday that it had signed a licensing deal with an international organisation that fights tuberculosis.
Aug 20, 2014
0
0
Scientists from the University of Sheffield have developed a novel antibody-based therapy which targets the progression of life threating kidney fibrosis.
Feb 14, 2014
0
0
College football exploits players in an "invisible labor market," and the only plausible way for student-athletes to address their interests is the credible threat of unionization, according to research from a University ...
Aug 23, 2012
0
0
Georgetown University Medical Center (GUMC) has licensed worldwide rights of a potential novel cancer therapy and diagnostic, or "theranostic," to BioMetrx, LLC. The agent was invented by two Georgetown researchers.
Jan 24, 2012
0
0
A new technology from the University of Minnesota has resulted in a startup that may help prolong the lives of victims suffering from massive blood loss or trauma. The university's Office for Technology Commercialization ...
Oct 18, 2011
1
0
CoPlex Therapeutics has signed an exclusive global license agreement with Hawthorn Pharmaceuticals to develop and commercialize hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other ...
Sep 22, 2011
0
0
